Reuters logo
3 个月前
BRIEF-Merus announces results from MCLA-128 phase 1/2 study
2017年5月17日 / 晚上9点17分 / 3 个月前

BRIEF-Merus announces results from MCLA-128 phase 1/2 study

May 17 (Reuters) - Merus Nv

* Merus announces promising results from MCLA-128 phase 1/2 study in metastatic breast cancer

* Phase 2 clinical trial to be initiated in second half of 2017 exploring two metastatic breast cancer populations

* Phase 2 study is expected to be launched in Europe and U.S. in second half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below